Ravelcare IPO Analyzed: Key Details for Investors
Ravelcare, a beauty and personal care brand, is going public with an Initial Public Offering (IPO). The IPO opens for subscriptions on December 1, 2025, aiming to raise ₹24.1 crore. This means the company is selling shares to the public for the first time. Investors should understand the basics to make smart decisions.
Key Points
- Ravelcare IPO raises ₹24.1 crore through new equity shares.
- Investors can bid between ₹123 and ₹130 per share.
- Minimum bid: 1,000 shares; investment starting at ₹260,000.
- Subscription window: 3 days, tentatively closing December 3, 2025.
- Shares listed on BSE SME platform, tentatively on December 8, 2025.
- Funds used: Marketing, new facility, and general corporate purposes.
The IPO offers investors the chance to buy shares in Ravelcare. The price range is set between ₹123 and ₹130 per share. Each application must be for at least 1,000 shares, requiring a minimum investment of ₹260,000 if you’re a small investor. Higher-value investors can buy larger lots.
The subscription period is expected to last for three days, potentially closing on December 3, 2025. After that, the company will decide who gets to own shares. The final decision will be made on December 4, 2025. Shares will then be listed on the BSE SME platform, likely on December 8, 2025.
Kfintech Technologies is handling the IPO process, and Marwadi Chandrana Intermediaries Brokers is the lead manager. Recent trading of the company’s unlisted shares shows strong investor interest, with shares trading at ₹146 per share on November 26, 2025.
Ravelcare’s financial performance has been growing. In FY25, the company reported revenue of ₹24.97 crore, a 13% increase from the previous year. Earnings before interest, tax, depreciation, and amortization (EBITDA) reached ₹6.81 crore. Profit after tax (PAT) was ₹5.25 crore, up 4.6%.
“Understanding the company’s growth and financial health is crucial for evaluating this investment opportunity.”



